« ARCHITECT CORE Reagent Kit, Calibrator and Controls The ARCHITECT | Main | FDA Requests Labeling Change for Leukotriene Modifiers The U.S. Food »

FDA Issues Safety Communication about an Ongoing Review of Stimulant


FDA Issues Safety Communication about an Ongoing Review of Stimulant Medications Used in Children with ADHD
There may be an association between the use of stimulant medications for attention- deficit hyperactivity disorder, known as ADHD, and sudden cardiac death in healthy children, according to a study published in the American Journal of Psychiatry. But the U.S. Food and Drug Administration says that, because of the study s limitations, parents should not stop a child s stimulant medication based on the study. The FDA recommends that parents should discuss concerns about the use of these medications with the prescribing health care professional.
Breaking FDA Recalls
Health Tip
  • It’s a little known fact that an espresso shot benefits your health in a variety of important ways.
Food & Drug Categories
 

©2006 FDA-News.com. All rights reserved.